,
"Ingredient Name in English","5,7-Dimethoxyphenanthrene-2,6-Diol"
2D-Structure,
"Molecular Formula",C16H14O4
"Molecular Weight",270.27996
ALogP,3.129
LogD,3.123
"Molecular Solubility",-3.862
"Molecular Volume",175.61
"Molecular Surface Area",258.38
"Molecular Polar Surface Area",58.92
"Num Rotatable Bonds",2
"Num H Acceptors",4
"Num H Donors",2
"ADMET Absorption Level",0
"ADMET BBB Level",2
"ADMET BBB",-0.128
"ADMET Solubility",-4.09
"ADMET Solubility Level",2
"ADMET Hepatotoxicity",1
"ADMET Hepatotoxicity Probability",0.953
"ADMET CYP2D6",1
"ADMET CYP2D6 Probability",0.772
"ADMET PPB Level",2
"Druglikeness Weight",0.702
"Druglikeness Grading",Good
"Candidate Target Genes","GABRA1 (0.8065), GABRA2 (0.8065), GABRA3 (0.8065), GABRA4 (0.8065), GABRA5 (0.8065), GABRA6 (0.8065), GABRG1 (0.8065), GABRG2 (0.8065), GABRG3 (0.8065), SHBG (0.8077)"
"Diseases Associated with This Ingredient","Hypomagnesemia, Cutaneous Photosensitivity, Generalized Tonic-Clonic Seizures, Abnormality Of Eye Movement, Increased Intramyocellular Lipid Droplets, Absence Seizures, Alcoholic Intoxication, Chronic, Neurodevelopmental Delay, Mildly Elevated Creatine Phosphokinase, Periodic Hypokalemic Paresis, Transient Hypophosphatemia, Exercise-Induced Muscle Fatigue, Anxiety Disorders, Cognitive Deficits, Urinary Retention, Late-Onset Proximal Muscle Weakness, Weight Loss, Atonic Seizures, Disorders Of Initiating And Maintaining Sleep, Thyrotoxicosis With Toxic Multinodular Goitre, Epileptic Encephalopathy, Aggressive Behavior, Lower Limb Muscle Weakness, Rhabdomyolysis, Hyperkalemia, Generalized Myoclonic Seizures, Shortened Pr Interval, Status Epilepticus, Photosensitive Tonic-Clonic Seizures, Psychomotor Retardation, Episodic Hypokalemia, Palpitations, Morning Myoclonic Jerks, Mood Disorders, Emg Abnormality, Thyrotoxicosis With Toxic Single Thyroid Nodule, Muscle Cramps, Bipolar Disorder, Focal Impaired Awareness Seizure, Dementia, Brain Injury, Respiratory Paralysis, Hemiclonic Seizures, Generalized Tonic-Clonic Seizures With Focal Onset, Focal Clonic Seizures, Insomnia, Abnormality Of The Mouth, Muscle Stiffness, Tetraplegia, Postprandial Hyperglycemia, Central Nervous System Diseases, Decreased Urinary Potassium, Hyperhidrosis, Obesity, Episodic Flaccid Weakness, Ataxia, Focal-Onset Seizure, Tremor, Delirium, Febrile Seizures, Constipation, Eeg Abnormality, Alzheimer's Disease"
"CAS No.",72966-94-0
"External Link to PubChem",10445823
"External Link to ChEMBL",CHEMBL1083093
References,16783700
"Herbs Containing This Ingredient","SHI HU"
"Formulas Containing This Ingredient","TONG MAI BAO GAO, HU PO HUAN QING WAN, FU FANG XIAN SHI HU KE LI, XIAO ER JIN SHI PIAN, AN SHEN WAN, QIANG JIN YING XIONG WAN, ZHI HONG WAN, BA BAO ZHI HONG WAN, TIAO JING BAI DAI WAN, ZHUANG GU WAN, FU FANG SHI HU PIAN, HAN WEN BI WAN (TIAN MA QU FENG WAN ), MAI LUO NING ZHU SHE YE, MO LUO DAN, MING JING DI HUANG WAN, YU BIAO WAN, KUN BAO WAN, YU FENG DAN, LING YANG QING FEI WAN, YUN FU QING HUO WAN, WU JI WAN, WEI AN JIAO NANG, LING YANG QING FEI KE LI, SHI HU MING MU WAN, WAN LING PIAN, TE LING YAN YAO, SHAN JI DA BU JIU, TONG SAI MAI PIAN, YIN XU WEI TONG PIAN, NING SOU WAN, QIANG XIN WAN, JIN SANG QING YIN WAN, BAO AN WAN LING DAN (BAO AN WAN LING WAN ), XIAO CUO WAN, JIE ER WAN LING WAN, ZHUANG YUAN SHEN HAI LONG JIU, FU MING PIAN, YIN XU WEI TONG KE LI, YU LU BAO FEI WAN, QING LIN WAN"
